HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M P Vincenti Selected Research

bardoxolone

5/2001A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M P Vincenti Research Topics

Disease

2Osteoarthritis
05/2001 - 04/2000
2Chondrosarcoma
05/2001 - 04/2000
1Inflammation (Inflammations)
01/2001
1Arthritis (Polyarthritis)
01/2001
1Connective Tissue Diseases (Connective Tissue Disease)
10/2000

Drug/Important Bio-Agent (IBA)

3Matrix Metalloproteinases (MMPs)IBA
05/2001 - 04/2000
3CytokinesIBA
05/2001 - 10/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2001 - 10/2000
2Interleukin-1 (Interleukin 1)IBA
10/2000 - 04/2000
2collagenase 1IBA
10/2000 - 04/2000
2NF-kappa B (NF-kB)IBA
10/2000 - 04/2000
1bardoxoloneIBA
05/2001
1CollagenIBA
05/2001
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2001
1Peptide Hydrolases (Proteases)FDA Link
01/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2001
1Transcription Factors (Transcription Factor)IBA
01/2001
1Collagenases (Collagenase)FDA Link
10/2000
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2000
1Matrix Metalloproteinase 13IBA
04/2000
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2000